Study identifies elevated serologic responses and memory CD8+ T cell clonal expansion as key markers of Long COVID, offering insights into its pathology and potential diagnostic approaches.
FDA clears Genentech’s Columvi for adults with R/R DLBCL
Genentech’s Columvi will become available in the US in summer 2023. Credit: Coolcaesar / commons.wikimedia.org. Roche Group member Genentech has secured approval from the US
June 16, 2023